CEO, Founder
Asha van Rooijen holds a master degree in Business Studies, Strategy from the University of Amsterdam. She founded LIPOSOMA in 2014 at Science Park, Amsterdam, with the vision of transforming healthcare through innovative liposomal and lipid-based products. She played a key role in the establishment of LIPOSOMA Health in 2019 and LIPOSOMA NutraTeq in 2024.
Asha has expertise in go-to-market strategies across multiple industries and successfully transitioned LIPOSOMA Health from a research-focused company into a global innovator.